This page is currently under review

The information on this page is under review and may no longer be accurate. Griffith web content is reviewed periodically to ensure it remains current. This page has passed its scheduled review date, however the replacement document has not yet been published.

Please contact the staff member responsible for site maintenance for further information. This is an automatically-generated message.

Content below this notice may be out of date.

Flip to Text Version
doubleHilex_a
doubleHilex_b
doubleHilex_c
doubleHilex_d
doubleHilex_e
doubleHilex_f
doubleHilex_g

RESEARCH GIVES HOPE TO MULTIPLE SCLEROSIS SUFFERERS - November 14, 2002

Professor Lyn Griffiths and her team, including PhD student Lotti Tajouri, at the Genomics Research Centre at Griffith University have identified 21 genes involved in Multiple Sclerosis (MS). Their studies have found that these genes are abnormally expressed, some increased and some decreased in affected brain tissue. MS is a serious neurological disorder affecting young people, with the onset usually between 18 and 40 years of age. With the exception of trauma, MS remains a major cause of neurological disability in young adults. In their preliminary studies, the Griffith researchers have isolated Ribonucleic Acid (RNA) from non-MS and MS-affected brain material and they have performed micro array analyses to identify genes showing abnormal expression. "If we can identify gene expression differences in affected and unaffected multiple sclerosis tissue, we may be able to define the genes involved in Multiple Sclerosis pathology and eventually explore therapeutic possibilities," Professor Griffiths said. "The aim is to identify genes involved in MS and then to investigate new methods of treatment," she said. Females account for about 60 per cent of MS cases around the world, and statistics from the United States estimate a person has a 1/1000 chance of developing the disease. This risk rises to 1/100, even to 1/50, for close relatives of a sufferer of MS, with a 1/3 chance for an identical twin of a sufferer developing the disease. The Genomics Research Centre has just recently identified these 21 target genes and is currently investigating the diagnostic and treatment possibilities associated with their studies. They are looking for Australian suffers wishing to help with their research. Participation would include answering a questionnaire and donating a blood sample also some medical history will be necessary from your doctor e.g. treatments, medications, method of diagnosis etc. It is not necessary to visit the GRC Clinic Volunteer Contact Sharon Quinlan or Carolyn Anderson (07) 55097300 Media Contact - Melissa Pizzato (07) 5552 9089 or 0408 727 706.

View other Press Releases

 

General GRC Photo - Professionals